VistaGen Therapeutics, Inc. (VTGN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0.58
Day's range
$0.62

Vistagen Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 05/15/2026 3.06 M $1.75 M   0.00% 7.25%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 2.68 M $1.53 M   0.00% 6.34%
05/15/2026 1.57 M $900.44 K   100.00% 3.73%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 751.14 K $429.28 K   20.46% 1.78%
STEMPOINT CAPITAL LP 05/18/2026 616.75 K $58.19 K   0.00% 1.46%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 589.66 K $336.00 K   100.00% 1.40%
IKARIAN CAPITAL, LLC 05/15/2026 519.08 K $296.65 K   0.00% 1.23%
TWO SIGMA INVESTMENTS, LP 05/15/2026 469.62 K $268.39 K   140.13% 1.11%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 453.39 K $259.17 K   28.50% 1.07%
BLACKROCK, INC. 05/13/2026 448.51 K $256.32 K   6.09% 1.06%
MILLENNIUM MANAGEMENT LLC 05/15/2026 430.40 K $245.98 K   118.43% 1.02%
LUMINUS MANAGEMENT LLC 05/15/2026 396.05 K $226.34 K   13.16% 0.94%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 291.30 K $166.48 K   81.17% 0.69%
ADVISORSHARES INVESTMENTS LLC 04/28/2026 277.11 K $158.37 K   10.76% 0.66%
JANE STREET GROUP, LLC 05/12/2026 272.81 K $155.91 K   -48.25% 0.65%
CITADEL ADVISORS LLC 05/15/2026 239.20 K $136.70 K   -38.13% 0.57%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 217.70 K $124.52 K   100.00% 0.52%
MILLENNIUM MANAGEMENT LLC 05/15/2026 214.00 K $122.30 K   100.00% 0.51%
VERDAD ADVISERS, LP 05/15/2026 184.94 K $105.69 K   100.00% 0.44%
XTX TOPCO LTD 05/15/2026 152.85 K $87.35 K   100.00% 0.36%
SHAY CAPITAL LLC 05/15/2026 144.45 K $82.55 K   100.00% 0.34%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 142.61 K $81.50 K   -57.40% 0.34%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 134.57 K $76.91 K   0.00% 0.32%
STATE STREET CORP 05/15/2026 121.11 K $69.22 K   0.00% 0.29%
TUDOR INVESTMENT CORP ET AL 05/15/2026 106.17 K $60.68 K   39.38% 0.25%
DIADEMA PARTNERS LP 05/15/2026 105.43 K $60.25 K   5.43% 0.25%
SIMPLEX TRADING, LLC 05/14/2026 89.65 K $51.28 K   100.00% 0.21%
UBS GROUP AG 05/05/2026 78.74 K $45.04 K   51.44% 0.19%
NORTHERN TRUST CORP 05/14/2026 72.66 K $41.52 K   0.00% 0.17%
PRUDENTIAL FINANCIAL INC 05/13/2026 53.10 K $30.35 K   100.00% 0.13%
GSA CAPITAL PARTNERS LLP 05/08/2026 49.84 K $28.00 K   100.00% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 40.40 K $23.03 K   -90.27% 0.10%
CITADEL ADVISORS LLC 05/15/2026 35.70 K $20.40 K   -92.32% 0.08%
PERSISTENT ASSET PARTNERS LTD 05/12/2026 26.61 K $15.21 K   0.00% 0.06%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2026 26.59 K $15.19 K   22.33% 0.06%
KESTRA ADVISORY SERVICES, LLC 04/30/2026 26.00 K $14.86 K   -0.13% 0.06%
HRT FINANCIAL LP 05/14/2026 25.37 K $14.00 K   -32.50% 0.06%
JANE STREET GROUP, LLC 05/12/2026 23.20 K $13.26 K   100.00% 0.05%
HIGHTOWER ADVISORS, LLC 05/05/2026 20.63 K $11.79 K   0.00% 0.05%
GROUP ONE TRADING, L.P. 05/13/2026 19.88 K $11.36 K   -81.27% 0.05%
TRUVESTMENTS CAPITAL LLC 05/13/2026 16.99 K $9.71 K   0.00% 0.04%
TWO SIGMA SECURITIES, LLC 05/15/2026 16.50 K $9.43 K   100.00% 0.04%
STONEX GROUP INC. 05/14/2026 15.20 K $8.69 K   13.85% 0.04%
RAYMOND JAMES FINANCIAL INC 05/14/2026 14.88 K $8.51 K   100.00% 0.04%
CAPTION MANAGEMENT, LLC 05/15/2026 14.66 K $8.38 K   -12.56% 0.03%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 10.81 K $6.18 K   100.00% 0.03%
PERFORMA LTD (US), LLC 05/06/2026 7.50 K $4.29 K   650.00% 0.02%
ADVISOR GROUP HOLDINGS, INC. 05/15/2026 4.13 K $2.36 K   -21.56% 0.01%
ROYAL BANK OF CANADA 05/15/2026 2.13 K $1.00 K   100.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 1.57 K $898   -81.64% 0.00%

Vistagen Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 79 institutional investors and hedge funds held shares of Vistagen Therapeutics Inc.. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 3.06 M

TCG Crossover Management, LLC: 2.68 M

ADAR1 Capital Management, LLC: 751,141

StemPoint Capital LP: 616,749

ACADIAN ASSET MANAGEMENT LLC: 589,663

Ikarian Capital, LLC: 519,077

34.88% of Vistagen Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 15.98 M shares in the last 24 months. This purchase volume represents approximately $9.91 M in transactions.